Drug
fam-trastuzumab deruxtecan-nxki
Marketed as ENHERTU.
Generic name
fam-trastuzumab deruxtecan-nxki
Brand names
ENHERTU
First FDA approval
2019-12-20
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761139 | ENHERTU | 2019-12-20 | DAIICHI SANKYO |
Manufacturers
DAIICHI SANKYO
Frequently asked questions
When was fam-trastuzumab deruxtecan-nxki FDA approved?
Earliest FDA approval on record: 2019-12-20.
What brand names are sold as fam-trastuzumab deruxtecan-nxki?
ENHERTU.
Sources
Appeal a fam-trastuzumab deruxtecan-nxki denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com